Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 19 | 2 | 16 | −1 |
| Shares | 1.87M | 60.0K | 1.93M | +117.8K (+6.5%) |
| Value | $2.05M | $66.0K | $1.79M | −$196.0K (−9.9%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (1)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EP Wealth Advisors, LLC | 50,000 | $47.0K | 0.00% |
Sold out (2)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Renaissance Technologies LLC | 10,804 | $12.0K |
| Cutler Group LP | 1,342 | $1.00K |
Not filed for Q3 2022 yet (2)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Minot Wealth Management LLC | 50,000 | $55.0K |
| B. Riley Wealth Management, Inc. | 10,000 | $11.0K |